Assessment of Comorbidity Burden and Treatment Response: Reanalysis of the SCD-HEFT Trial
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Geriatrics and Gerontology
Link
https://link.springer.com/content/pdf/10.1007/s40266-021-00915-w.pdf
Reference23 articles.
1. Boersma, P, Black, L. Prevalence of multiple chronic conditions among US adults, 2018. Research brief—vol. 17—September 17, 2020. CDC. https://www.cdc.gov/pcd/issues/2020/20_0130.htm. Accessed 27 July 2021.
2. Ruzieh M, Mandrola J, Dyer A, Chinchilli VM, Naccarelli GV, Foy AJ. A Multimorbidity-based, risk-stratified reanalysis of the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) trial. Drugs Aging. 2020;37:839–44.
3. Bardy GH, Lee KL, Mark DB, Poole JE, Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225–37.
4. Brilleman SL, Salisbury C. Comparing measures of multimorbidity to predict outcomes in primary care: a cross sectional study. Fam Pract. 2013;30(2):172–8. https://doi.org/10.1093/fampra/cms060.
5. Huntley AL, Johnson R, Purdy S, Valderas JM, Salisbury C. Measures of multimorbidity and morbidity burden for use in primary care and community settings: a systematic review and guide. Ann Fam Med. 2012;10(2):134–41. https://doi.org/10.1370/afm.1363.
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Re-Analyses of 8 Historical Trials in Cardiovascular Medicine Assessing Multimorbidity Burden and Its Association with Treatment Response;The American Journal of Medicine;2024-07
2. Evaluation of MADIT-II Risk Stratification Score Among Nationwide Registry of Heart Failure Patients With Primary Prevention Implantable Cardiac Defibrillators or Resynchronization Therapy Devices;The American Journal of Cardiology;2024-01
3. Can Risk Stratification Scores Improve Selection Of Patients Who Need Primary Prevention Implantable Cardioverter-Defibrillators Or Should We Just Follow The Rules?;The American Journal of Cardiology;2024-01
4. Correction to: Assessment of Comorbidity Burden and Treatment Response: Reanalysis of the SCD-HEFT Trial;Drugs & Aging;2022-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3